{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:32:00Z","timestamp":1648830720102},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.parkreldis.2014.02.017","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T06:15:44Z","timestamp":1393568144000},"page":"680-681","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on Numao et\u00a0al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy"],"prefix":"10.1016","volume":"20","author":[{"given":"Marina","family":"Picillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Erro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Pellecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2014.02.017_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.parkreldis.2013.11.005","article-title":"Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy","volume":"20","author":"Numao","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.02.017_bib2","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00415-013-6851-0","article-title":"Insulin like growth factor-1 and progression of motor symptoms in early, drug-naive Parkinson's disease","volume":"260","author":"Picillo","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2014.02.017_bib3","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/mds.23320","article-title":"Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system","volume":"25","author":"Pellecchia","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.02.017_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jnnp.2009.175752","article-title":"Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease","volume":"81","author":"Godau","year":"2010","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.parkreldis.2014.02.017_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archneurol.2011.129","article-title":"Serum insulin like growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease","volume":"68","author":"Godau","year":"2011","journal-title":"Arch Neurol"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T04:58:12Z","timestamp":1538801892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802014000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1353802014000704"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on Numao et\u00a0al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.11.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}